Raphael Pharmaceutical (RAPH) Retained Earnings (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Retained Earnings of -$10.2 million for Q4 2025, down 2.76% sequentially from -$9.9 million in Q3 2025, and down 14.39% YoY from -$11.9 million in Q4 2024.
Raphael Pharmaceutical (RAPH) Retained Earnings (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Retained Earnings for 6 years, with the latest figure at -$10.2 million in Q4 2025.
- Quarterly Retained Earnings fell 14.39% year-over-year to -$10.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$10.2 million (down 14.39% YoY) and the FY2025 annual result came in at -$10.2 million, down 14.39% from the prior year.
- Retained Earnings retreated to -$10.2 million in Q4 2025 per RAPH's latest filing, from -$9.9 million in the prior quarter.
- Over five years, Retained Earnings peaked at $7.2 million in Q3 2023 and troughed at -$10.2 million in Q4 2025.
- A 5-year average of -$3.3 million and a median of -$6.7 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2021 and 2022: Retained Earnings surged 355.51% in 2021, then sank 326.12% in 2022.
- Over 5 years, Retained Earnings stood at $2.7 million in 2021, then sank by 326.12% to -$6.0 million in 2022, then fell by 22.3% to -$7.4 million in 2023, then retreated by 20.61% to -$8.9 million in 2024, then dropped by 14.39% to -$10.2 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered -$10.2 million, -$9.9 million, and -$9.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 3.75 Bn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | -10.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.17 Mn |
| Sep 30, 2025 | -9.90 Mn |
| Jun 30, 2025 | -9.64 Mn |
| Mar 31, 2025 | -9.32 Mn |
| Dec 31, 2024 | -8.89 Mn |
| Sep 30, 2024 | -8.43 Mn |
| Jun 30, 2024 | -8.11 Mn |
| Mar 31, 2024 | -7.86 Mn |
| Dec 31, 2023 | -7.37 Mn |
| Sep 30, 2023 | 7.18 Mn |
| Jun 30, 2023 | 6.48 Mn |
| Mar 31, 2023 | 6.12 Mn |
| Dec 31, 2022 | -6.03 Mn |
| Sep 30, 2022 | 4.71 Mn |
| Jun 30, 2022 | 3.45 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | 2.67 Mn |
| Sep 30, 2021 | -2.10 Mn |
| Dec 31, 2020 | -1.04 Mn |